BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2013
View Archived Issues
Ascorbix presents novel agents for cancer
Read More
Italian researchers patent new photosensitizing agents
Read More
Suzhou NeuPharma discloses novel arctigenin derivatives for cancer
Read More
HSCI obtains approval in Ukraine for Neovasculgen
Read More
Biosantech initiates phase I/II trial of synthetic AIDS vaccine Tat Oyi
Read More
Activin betaC expression plays a role in the progression of prostate disease
Read More
HAT-01: a novel herbal preparation for the treatment of atopic dermatitis
Read More
Katanin enzyme complexes necessary for male fertility
Read More
UCB reflects on achievements of 2012
Read More
Researchers at Ascendis Pharma synthesize novel prodrugs of paliperidone
Read More
Promethera Biosciences opens French site in phase I/II HepaStem trial
Read More
BioLineRx's candidate for severe and persistent asthma to enter main pipeline
Read More
Novan Therapeutics reports preclinical data for topical sebum inhibitor
Read More
Trophos confirms positive interim review for pivotal olesoxime trial
Read More
Life Technologies signs stem cell research agreement
Read More
NIBP expression shows partial correlation with breast tumor staging
Read More
FDA accepts filing of BLA for recombinant factor IX Fc fusion protein
Read More
FDA agrees with La Jolla Pharmaceutical's proposed IND for LJPC-501
Read More
Immuron reports preclinical data for IMM-529
Read More
Sarepta Therapeutics reports data from non-human primate study of AVI-7288
Read More
VX-787 shows antiviral activity in phase II influenza challenge study
Read More
EMA grants orphan drug status to Prothena's candidate for amyloid light-chain amyloidosis
Read More
Researchers at Merck KGaA design new RON inhibitors
Read More
HH1.5 shows potential as a novel biomarker in prostate cancer
Read More
Verona's RPL-554 demonstrates anti-inflammatory activity in exploratory trial
Read More
Health Canada declines to approve Theratechnologies' NDS for Egrifta
Read More